#Globalhealth

A new study published in BMC Public Health has cast a spotlight on Ghana’s journey in expanding access to modern family planning methods, drawing attention to both impressive achievements and lingering disparities over the past decade. The research, titled “Demand for family planning satisfied by modern methods in Ghana: trends and inequalities (2013–2022),” provides updated insights into how Ghana is addressing reproductive health—a topic with growing resonance for policymakers and public health experts across the developing world, including Thailand (BMC Public Health).

A new study in BMC Public Health examines Ghana’s decade-long journey to expand access to modern family planning. The research, titled Demand for family planning satisfied by modern methods in Ghana: trends and inequalities (2013–2022), highlights both notable progress and persistent gaps in reproductive health.

Data show a steady rise in the share of Ghanaian women whose demand for modern contraception is met. This trend reflects ongoing government and partner efforts to broaden services, diversify available methods, and boost public awareness. The findings align with global targets that emphasize universal access to reproductive health under Sustainable Development Goal 3.

New research and commentary have intensified calls for urgent action to protect reproductive health data, as recent legal cases in the United States and rapid growth of health-tracking technology expose gaps in data privacy protections with potential global implications, including for Thailand. The conversation arises amid the prosecution of individuals, such as a Nebraska teenager whose private messages were used as evidence in violating abortion laws, and the adoption of telehealth abortions and digital health tools following major changes to American abortion rights.

A proposed Republican-led budget plan to cut Medicaid—the United States’ largest public health program—could raise costs and reduce access to essential reproductive health services for millions of women. Health advocates warn that low-income women, communities of colour, people with disabilities, and rural residents may lose affordable care, including contraception, prenatal care, and important screenings.

For Thai readers, the U.S. debate serves as a cautionary tale about public healthcare funding. Medicaid currently covers more than 70 million people, including about 13 million women of reproductive age, and is a government-led effort to protect vulnerable populations. This bears some resemblance to Thailand’s 30-baht universal health coverage scheme, known locally as the gold card system.

A newly released international report assessing the landscape of contraceptive supplies provides crucial insights for family planning stakeholders worldwide, with implications for policy and practice in Thailand. The 2024 Family Planning Market Report, jointly published by the Clinton Health Access Initiative and the Reproductive Health Supplies Coalition, delivers an extensive analysis of the evolving global market for reproductive health commodities, highlighting both progress and ongoing challenges in ensuring access to contraceptives for millions of women and couples.

Proposed Republican-led budget cuts to Medicaid—the United States’ largest health insurance programme—could drastically increase healthcare costs and reduce access to essential health services for millions of women, according to recent reports. The potential policy shift is raising concerns among health advocates and experts who warn that low-income women, communities of colour, those with disabilities, and rural residents may be left without affordable care, including birth control, prenatal services, and vital screenings.

Recent research and commentary heighten calls to protect reproductive health data as legal cases in the United States and the rapid rise of health-tracking technology reveal gaps in privacy safeguards. These developments carry global implications, including for Thailand, where digital health tools are expanding rapidly.

For Thai readers, the issue offers a timely lens on how technology, health, and law intersect. The trend toward criminalizing reproductive decisions through digital footprints underscores the need for strong data policies and public awareness, especially as similar technologies and legal gaps may emerge in Thailand’s context. Health-tracking apps and telehealth services are growing, making privacy protections more important than ever.

A new international analysis of contraceptive supplies offers timely guidance for Thailand’s reproductive health efforts. The 2024 Family Planning Market Report, produced by the Clinton Health Access Initiative and the Reproductive Health Supplies Coalition, maps market trends, price dynamics, and supply chain challenges that shape access to contraception worldwide.

This tenth edition serves as a benchmark for donors, governments, NGOs, and medical suppliers involved in low- and middle-income countries. It examines market size, procurement patterns, and the impact of lingering COVID-19 disruptions, while highlighting how new technologies are changing choices for women and couples. For Thailand, known for pioneering family planning programs, the findings illuminate gaps and opportunities amid demographic shifts and regional health concerns.

A wave of clinic closures is unfolding in the United States as the federal freeze on Title X family planning funds continues. The suspension threatens access to contraception, cancer screenings, STI testing, and other preventive services for low-income communities. Many clinics have reduced hours, laid off staff, or shut their doors, highlighting the fragility of public health safety nets under political decisions. This situation offers important lessons for health policy in Thailand as it seeks to maintain accessible reproductive health services.

Diabetes deaths in the United States have dropped to their lowest levels in recent years, according to early figures from the Centers for Disease Control and Prevention (CDC), signalling pivotal progress against one of the world’s most persistent chronic diseases. The preliminary data, released this week, show a significant decline in diabetes-related mortality, prompting cautious optimism among healthcare professionals and patients alike CBS News.

For Thailand, where diabetes is one of the top three leading causes of death and a major public health concern, this trend is particularly relevant. Thai health officials and specialists regularly reference global best practices to inform local strategies. The dramatic reduction in diabetes deaths seen in the US, if proven durable, could offer valuable insights for policymakers at the Ministry of Public Health and clinicians across the country.

New, early CDC figures show diabetes deaths in the United States have fallen to their lowest level in years, signaling notable progress against a major chronic disease. The preliminary data suggest a genuine decline in mortality, prompting cautious optimism among clinicians and patients.

For Thailand, where diabetes ranks as one of the top three causes of death, this trend resonates strongly. Thai health officials commonly reference global best practices to shape local policies. If the US decline proves durable, it could provide valuable insights for the Ministry of Public Health and clinicians nationwide.

A new set of guidelines from the World Health Organization aims to curb the rising trend of medicalized female genital mutilation (FGM) and to improve care for survivors. Health experts view this as a crucial step toward ending FGM globally, with focus on health, legal, and ethical implications when health professionals are involved.

FGM refers to procedures that intentionally injure the female genital organs for non-medical reasons. The World Health Organization estimates that more than 200 million girls and women alive today have undergone FGM, with millions more at risk each year. Disturbingly, recent research shows a surge in FGM performed by doctors, nurses, or midwives. While some communities view medicalized FGM as safer, global health authorities and women’s rights advocates agree there is no safe form of FGM, and medicalization perpetuates gender inequality and violence. Research and guidance from leading health institutions underscore this stance.

The World Health Organization (WHO) has released groundbreaking new recommendations to curb the growing trend of “medicalized” female genital mutilation (FGM) and strengthen care for survivors, a move hailed by global health experts as an essential step toward eliminating this harmful practice worldwide. This updated guidance is particularly relevant as rising evidence suggests that, despite global efforts to end FGM, a concerning number of procedures are being performed by healthcare professionals—a development with complex health, legal, and ethical implications.

A new set of urgent recommendations from the World Health Organization aims to curb the rise of medicalized female genital mutilation (FGM) and strengthen care for survivors. The guidance, released April 28, 2025, marks a significant step in the global effort to eradicate FGM and protect girls’ health and rights.

FGM involves partial or total removal of external female genitalia for non-medical reasons and carries serious health risks and human-rights violations. As more procedures are reported to be carried out by healthcare professionals—an trend known as medicalization—the WHO calls for stronger legal and policy actions to discourage this practice and to expand survivor support services. Health experts emphasize that no form of FGM is safe or ethical, regardless of the setting or provider.

The World Health Organization (WHO) has issued urgent new recommendations aimed at stopping the dangerous trend of “medicalized” female genital mutilation (FGM) and ensuring robust support for women and girls who have undergone the practice, according to a recent release. This latest guidance, announced on April 28, 2025, is seen as a pivotal step in the global fight to eradicate FGM, a deeply harmful practice affecting millions worldwide.

FGM, which involves the partial or total removal of external female genitalia for non-medical reasons, poses severe health risks and violates fundamental human rights. In response to mounting evidence that a growing share of FGM procedures are now performed by healthcare professionals—a process known as “medicalization”—the WHO is calling for stricter measures to discourage this troubling shift while intensifying care for survivors.

Global efforts to combat childhood malnutrition are facing a dangerous setback as disruptions in US government funding threaten the distribution of Plumpy’Nut, a ready-to-use therapeutic food (RUTF) that has transformed survival rates for severely malnourished children. Experts warn that millions could be left without this critical lifeline, triggering renewed concern across regions already suffering humanitarian emergencies.

For families like those in northeastern Nigeria, the stakes are heartbreakingly clear. After losing her husband to violence and fleeing her village, one mother found her two-year-old son failing to thrive on inadequate rations in a displaced persons camp. It was only after receiving Plumpy’Nut—an energy-dense peanut paste fortified with vitamins and minerals—that her son rapidly recovered from acute malnutrition, illustrating the product’s vital role on the frontlines of humanitarian care (source: NPR).

A global effort to combat childhood malnutrition faces a dangerous disruption as U.S. funding shifts threaten the distribution of Plumpy’Nut, a ready-to-use therapeutic food that has dramatically improved survival for severely malnourished children. Experts warn that millions could lose access to this critical lifeline, intensifying humanitarian strain in regions already under pressure.

In northeastern Nigeria, a mother who fled violence with her two-year-old son recalls the turning point. Her child, once stunted by inadequate rations in a displacement camp, rapidly recovered after receiving Plumpy’Nut, a nutrient-dense peanut paste fortified with vitamins and minerals. This example underscores the program’s frontline importance in emergency settings.

Millions of children in the United States are diagnosed with attention-deficit hyperactivity disorder (ADHD), and the vast majority are prescribed stimulant medications such as Ritalin and Adderall. However, a new wave of research reported by NPR and detailed in The New York Times Magazine raises pressing questions about the effectiveness and long-term consequences of these treatments, as well as the very nature of ADHD itself (NPR, 2025).

The U.S. Centers for Disease Control and Prevention (CDC) revealed last year that more than 11% of American children had received an ADHD diagnosis—a record high, and a dramatic increase from the early 1990s figure of just 2 million. In 14-year-old boys, the rate soars to 21%. These statistics portray a nation deeply invested in identifying—and medicating—children with ADHD. But why are diagnoses rising, and are treatments truly serving those diagnosed?

A recent national survey in England has found that one in four women is living with a serious reproductive health issue, shedding new light on the scale of gynecological challenges and potentially offering important lessons for Thailand’s healthcare system. The findings signal the persistent and pervasive nature of conditions such as endometriosis, polycystic ovary syndrome (PCOS), persistent pelvic pain, and heavy menstrual bleeding. The study underscores the urgent need for improved screening, public awareness, and healthcare accessibility—issues that are equally resonant for Thai women.

A nationwide English survey finds that about 25% of women live with a serious reproductive health issue. The study highlights common conditions such as chronic pelvic pain, heavy or irregular bleeding, and hormonal disorders like endometriosis and PCOS. The findings call for better screening, public awareness, and accessible care—issues that matter for Thai women as well.

In Thailand, reproductive health is essential but often under-discussed due to cultural sensitivities and limited public dialogue. Delayed diagnosis and treatment are more likely for teenagers and women in rural areas. The English results invite Thai policymakers and healthcare professionals to re-evaluate strategies and engage communities on women’s health.

A growing debate over ADHD medications is reshaping how clinicians, educators, and parents view attention challenges. New reporting highlights questions about long-term benefits and potential risks of stimulant drugs like methylphenidate and amphetamine-based medicines. While these medications can produce quick improvements in focus and behavior, experts warn that lasting academic gains are not guaranteed and that ADHD itself may reflect a mix of biological and environmental factors.

In many places, including Thailand, ADHD diagnoses are rising. Health authorities emphasize careful assessment to distinguish ADHD from anxiety, trauma, and learning difficulties. Data from researchers suggests that three out of four children diagnosed with ADHD also have another related issue, underscoring the need for a holistic approach. Some scholars argue that ADHD symptoms exist on a spectrum and may not represent a fixed, lifelong brain disorder.

A rising tide of research and real-world experience is challenging the notion that parenting should be a solitary journey. In a compelling new article from The Guardian, journalist Marina Lopes shares five vital lessons from communities around the globe—Mozambique, Brazil, Malaysia, the Netherlands, and Singapore—highlighting the profound benefits of communal parenting, intergenerational support, and greater independence for children (“Please, yell at my kids! Five lessons I’ve learned about good parenting from around the world” The Guardian, 2025). Lopes’ revelations echo a growing body of research and hold special significance for Thai families balancing tradition and modernity in a time of rapid social change.

A new analysis of cancer prevention in the United States shows both progress and new challenges. Smoking rates are at historic lows, but HPV vaccination among teens has stalled. The findings offer timely lessons for Thailand, where cancer remains a leading cause of death and prevention campaigns must address both established and emerging risks.

The continued fall in smoking is a public health success. Decades of awareness campaigns, policy measures, and higher prices have driven adults away from tobacco. The World Health Organization notes similar downward trends in many countries, though progress is not uniform. In Thailand, smoking rates have eased—particularly among women and urban youths—but a sizable portion of men still use tobacco. Data from Thailand’s Ministry of Public Health indicates about 17% of Thais over 15 are smokers, a figure higher than the current U.S. rate of around 11%. This places Thai policymakers on watch as tobacco-related cancers continue to burden the healthcare system.

A recent report on cancer prevention trends in the United States has delivered both hopeful and concerning findings: while smoking rates continue their historic decline, vaccination rates against human papillomavirus (HPV)—a leading cause of cervical and other cancers—have stalled. This research carries important lessons for Thailand, where cancer remains a leading cause of death and where public health campaigns must juggle both familiar and emerging risks (CNN, 2025).

The continued drop in smoking rates is seen as a major victory for US public health. Decades of anti-smoking campaigns, policy changes, and increased public awareness have pushed adult smoking rates in the US to all-time lows. Globally, the World Health Organization (WHO) points to similar downward trends in high- and some middle-income countries, though progress is uneven. In Thailand, while smoking rates have decreased somewhat—especially among women and urban youth—a significant portion of the male population still uses tobacco products. According to the Ministry of Public Health, about 17% of Thais over 15 are smokers, higher than the current US adult smoking rate of around 11% (Thai National Statistics Office, 2023; CDC, 2024). This positions the new US numbers as benchmarks for Thai policymakers, especially as tobacco-related cancers continue to challenge the country’s healthcare system.